Endoscopic Mucosal Resection Market Size, Share, Growth, and Regional Forecast, 2025 to 2032

The global endoscopic mucosal resection market size is valued at US$ 1.5 billion in 2025 and projected to reach US$ 1.9 billion at a CAGR of 4.8% during the forecast period from 2025 to 2032.

The global endoscopic mucosal resection market is growing steadily due to rising gastrointestinal cancer cases and increasing adoption of minimally invasive procedures. North America leads with advanced endoscopy infrastructure and high procedural volumes. Asia Pacific is the fastest-growing region, driven by expanding endoscopy centers, government investment in GI cancer care, improved screening programs, and greater involvement of global device manufacturers.

• Dominant Indication: Colon cancer accounts for roughly 55.6% of the EMR market, supported by high global colorectal cancer prevalence and strong adoption of EMR as a first-line minimally invasive therapy.
• Dominant Region: North America holds about 40.4% market share, driven by advanced endoscopy infrastructure, strong screening programs, and high procedure volumes.
• Investment Plans: Asia Pacific is the fastest-growing region, propelled by expanding endoscopy centers, rising GI cancer screening, government funding, and partnerships between local hospitals and global endoscopy device manufacturers.
• Market Drivers: Growth is fueled by rising gastrointestinal cancer burden, increasing preference for minimally invasive endoscopic therapies, advancements in EMR devices, and improved hospital endoscopy capacity.
• Market Opportunity: Development of next-generation EMR tools, integration with image-guided and AI-assisted systems, localized device manufacturing, and expansion into emerging markets with improving healthcare access.

Driver - Growing Adoption of Minimally Invasive Endoscopic Procedures Driven by Technological Advancements and Improved Healthcare Infrastructure

The rise in endoscopic mucosal resection procedures is improving which has facilitated complicated medical procedures for the patients. With the increase in investments by the government in the healthcare industry, there is an ample amount of advanced equipment available to the authorities and also the experts who know how to use it.

The endoscopy procedures are done through a small incision or the body opening, which leads to a lower chance of infection as compared to traditional operative procedures. The use of endoscopes reduces healthcare expenditure significantly.

The endoscopy procedures also take a short time and results in shorter hospitable stay with low risk of complication. The aforesaid post-operative benefits of the endoscope technique propel the market demand for endoscopes and drive the market of endoscope mucosal resection in some regions.

Restraints - High Cost Associated with the Endoscopic Mucosal Resection Techniques may Hamper the Growth of the Market

The initial set up and installation of endoscope reprocessing equipment along with steep repair and service costs involves high investments. A limited financial support in remote locations may lead to the chances of recovering costs as return on investment totally depends on the number of procedures happening on a daily basis.

Hence, achieving break-even is quite uncertain and entails high risk. Also, the global market’s growth largely depends on the availability of robust medical facilities and platforms. Additionally, the high costs involved in upgrading hi-tech endoscope devices and repairing and refurbishment services could also hamper revenue growth of the global market during the forecast period.

Opportunity - Next-Generation EMR Devices & Accessories

The rapid rise of next-generation EMR devices and accessories presents a compelling opportunity in the Endoscopic Mucosal Resection market. With over 1.9 million new colorectal cancer cases globally in 2022 and projections reaching 3.2 million by 2040, demand for advanced, precise, and safe removal tools is surging.

Innovative EMR devices, like AI-assisted imaging snares, smart injection systems, and endoscopes with computer-aided lesion detection, can reduce complications, shorten procedure times, and improve polyp detection. Moreover, reducing post-operative risks and hospital stays aligns with public-health goals: in the U.S., colorectal cancer treatment cost reached US$ 24.3 billion in 2020, per CDC data.

By delivering better outcomes and economic value, next-gen EMR technologies can expand adoption and unlock substantial market growth.

By Technology, Lift-and-Cut Technique Dominates the Endoscopic Mucosal Resection Market

Lift-and-Cut Technique occupied 57.6% share of the global market in 2024, because it is widely regarded by clinicians as the safest and most controlled approach for removing large or flat gastrointestinal lesions. Its submucosal injection step creates a protective cushion, giving endoscopists better visualization, improved maneuverability, and reduced risk of deep tissue injury.

Medical societies consistently recommend injection-based EMR as the preferred method for complex colorectal and gastric lesions due to its predictable performance and lower complication profile compared with suction-based methods.

Hospitals and endoscopy centers also favor it because it supports consistent training, works well across different lesion types, and aligns with standardized procedural guidelines. These qualitative advantages make lift-and-cut the technique most trusted by endoscopists, driving its dominant market position.

By Indication, Colon Cancer is gaining traction due to high global incidence and widespread removal of precancerous polyps

Colon cancer dominates the Endoscopic Mucosal Resection (EMR) market because colorectal cancer is one of the most commonly diagnosed cancers globally, creating strong clinical demand for minimally invasive polyp and early-tumor removal. According to the World Cancer Research Fund, there were 1.93 million new colorectal cancer cases in 2022, making it the third most common cancer worldwide.

The CDC reports that in the U.S. alone, 147,931 new colorectal cancer cases were recorded in 2022, and most begin as precancerous polyps that can be effectively removed using EMR. With nearly 70% of U.S. adults aged 50-75 up to date with colorectal screening, early lesion detection is increasing. This drives high procedure volumes, positioning colon cancer as the dominant EMR indication.

North America Endoscopic Mucosal Resection Market Trends

North America dominates the endoscopic mucosal resection market with 40.4% share in 2025, because the region performs one of the highest volumes of gastrointestinal endoscopic procedures globally, supported by advanced healthcare infrastructure and strong screening programs. In the United States alone, an estimated 20 million GI endoscopies are conducted each year, according to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Colonoscopy capacity has also been historically high, with surveys showing 15 million procedures annually, along with the ability to perform 10.5 million more if required. This large procedural base is driven by aggressive colorectal cancer screening, with nearly 70% of adults aged 50-75 up to date with screening (CDC). These factors collectively boost EMR adoption, keeping North America the leading regional market.

Europe Endoscopic Mucosal Resection Market Trends

Europe is an important region in the endoscopic mucosal resection market because it carries a high burden of colorectal and other gastrointestinal cancers, which increases the need for early detection and minimally invasive treatment. According to the European Cancer Information System (ECIS), the EU recorded 356,000 new colorectal cancer cases in 2022, representing one of the highest regional incidences worldwide.

Mortality rates also remain significant, with some countries reporting over 40 deaths per 100,000 men. To address this, Europe has strong national screening programs, supported by EU recommendations for population-based colorectal cancer screening. These programs detect large numbers of precancerous polyps suitable for EMR. Combined with advanced endoscopy infrastructure and skilled specialists, these factors make Europe a key EMR market.

Asia Pacific Endoscopic Mucosal Resection Market Trends

Asia Pacific is the fastest-growing region in the EMR market primarily because of a surging colorectal cancer burden and rapid expansion of endoscopy infrastructure. In 2022, Asia accounted for 50.2% of global colorectal cancer cases, with 966,400 new diagnoses and 462,300 deaths.

Many countries, including Japan, South Korea, and Taiwan are scaling up national CRC screening programs as lifestyles westernize and risk factors (like obesity and smoking) rise. A 2021 regional survey of 162 endoscopy centers across 13 Asia Pacific nations showed steady growth in therapeutic endoscopies, including polypectomy. This combination of high disease incidence and expanding GI-endoscopy capacity makes APAC a high-opportunity market for EMR.

Leading companies in the endoscopic mucosal resection market focus on device innovation, precision endoscopy tools, and strategic clinical collaborations. They invest in enhanced snares, improved electrosurgical systems, and AI-assisted visualization to boost accuracy, safety, and consistency. Companies also expand training programs and global distribution to meet rising demand for minimally invasive gastrointestinal cancer management.

Key Industry Developments:

• In May 2025, Olympus announced that it had received FDA clearance for its most advanced imaging endoscopes, marking a major milestone in its endoscopy portfolio. The company stated that the newly cleared devices had delivered enhanced visualization, improved lesion detection, and greater procedural precision for clinicians.
• In April 2025, Olympus Canada announced that it had expanded its exclusive distribution agreement with EndoClot Plus, Inc., strengthening its hemostasis solutions portfolio across the country. The company stated that the expanded agreement had enabled broader access to EndoClot’s advanced gastrointestinal bleeding management products for Canadian hospitals and endoscopy centers.
• In March 2025, Olympus announced that it had launched its new single-use hemostasis clip in the United States, aiming to enhance bleeding control during gastrointestinal procedures. The company reported that the device had been designed to offer improved precision, easier deployment, and greater procedural safety.